Your Messages Inbox
Your Article Summary
See Latest ArticlesApproval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/12/09
Chugai Pharmaceutical Co., Ltd. announced that the company has acquired the approval for the partial change of the API manufacturing method and the pharmaceutical formulation of a recombinant human erythropoietin from the Japanese Ministry of Health, Labour and Welfare on April.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
US FDA approves SEROQUEL for the pediatric treatment of schizophrenia and bipolar mania
AstraZeneca, 12/07/09
US FDA approves SEROQUEL XR for add-on treatment of Major Depressive Disorder
AstraZeneca, 12/07/09
FDA Approves Initiation of Clinical Studies in the U.S. for T2000, Taros Proprietary Non-Sedating Barbiturate Compound
Taro Pharmaceuticals USA, 12/07/09
Article Search
Sponsor